In immuno-oncology, GM-CSF has been proposed as a potent immunostimulatory adjuvant for vaccination against cancer cells; it was shown to recruit and activate dendritic cells and thus promotes the development of antigen-specific T cells.60 Here, CSF2 is linked to cancer.